A model for the harmonisation of test results of different quantitative D-dimer methods

Summary

The numerical test results of different D-dimer assays vary widely. Because of the complexity of the analyte of target as well as the variability in specificity of different D-dimer assays, only harmonisation of the test results seems to be feasible. The use of a single conversion factor does not take into account for several methods the lack of commutability between test results and consensus values at different D-dimer levels. This is probably related to the mutually different response of methods to high and low levels. We therefore designed a harmonisation model based on the transformation of a method-specific regression line to a reference regression line. We used the data for the measurement of a set of plasma samples with different D-dimer levels by 353 different laboratories using 7 of the most frequently used quantitative D-dimer methods. For each method we calculated the method-specific consensus value for each sample. The overall median value was also estimated. Per method linear regression was applied throughout the method-specific consensus values using the amount of patient pooled plasma added to the different plasma samples as the independent variable. The line through the overall median values of all 7 methods was used as the reference line. Harmonisation between the methods was obtained by transformation of the method-specific regression line to the reference line. This harmonisation resulted in a reduction of the variability between the method-specific consensus values from about 75% to about 5.5%. Clinical validation of this concept had shown significant improvement of the test result comparability. We conclude that this model isa feasible approach in the harmonisation of D-dimer methods. If the harmonisation procedure is included in the calibration procedure by the manufacturers, customers will automatically obtain harmonised test results.

Keywords

D-dimer - harmonisation - linear regression - commutability

• References

• 1 Janssen MCH, Wollersheim H, Verbruggen B. et al. Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: current status and new developments. Semin Thromb Haemost 1998; 24: 393-400.
• 2 Reber G, De Moerloose P. D-dimer assays for the exclusion of Venous Thromboembolism. Semin Thromb Hemost 2000; 26: 619-24.
• 3 Dempfle CE, Ergül Zips S. et al. The fibrin assay comparison trial (FACT). Evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. Thromb Haemost 2002; 85: 671-8.
• 4 De Maat MPM, Meijer P, Nieuwenhuizen W. et al. Performance of semiquantitative and quantitaive Ddimer assays in the ECAT external quality assessment programme. Semin Thromb Haemost 2000; 26: 625-30.
• 5 Koopman J, Haverkate F, Koppert PW. et al. New immunoassay for fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Clin Lab Med 1987; 109: 75-84.
• 6 Gaffney PJ, Edgell T, Creighton-Kempsford LJ. et al. Fibrin degradation product (FnDP) assays: analysis of standardisation issues and target antigens in plasma. Br J Haematol 1995; 90: 187-94.
• 7 Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Thromb Haemost 1997; 77: 1031-3.
• 8 Spannagl M, Haverkate F, Reinauer H. et al. The performance of quantitative D-dimer assays in laboratory routine. Blood Coag Fibrinolysis 2005; 16: 439-43.
• 9 Walker JB, Nesheim ME. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. JBC 1999; 274: 5201-12.
• 10 Elias A, Aptel I, Huc B. et al. D-dimer test and diagnosis of deep vein thrombosis: a comparative study of 7 assays. Thromb Haemost 1996; 76: 518-22.
• 11 Freyburger G, Trillaud H, Labrouche S. et al. D-dimer strategy in thrombosis exclusion. A gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost 1998; 79: 32-7.
• 12 Van der Graaf F, Van de Borne H, Van der Kolk M. et al. Exclusion of deep venous thrombosis with D-dimer testing. Comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000; 83: 191-8.
• 13 Gosselin RC, Owingts JT, Kehoe J. et al. Comparison of six D-dimer methods in patients suspected of deep vein thrombosis. Blood Coag Fibrinolysis 2003; 14: 545-50.
• 14 Schutgens RE, Haas FJ, Ruven HJ. et al. No influence of heparin and other (pre)analytic varia on D-dimer determination. Clin Chem 2003; 49: 1483-90.
• 15 Schutgens RE, Haas FJ, Gerritsen WB. et al. J Thromb Haemost 2003; 01: 976-81.
• 16 Stein PD, Hull RD, Patel KC. et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140: 589-602.
• 17 Heim SW, Schectman JM, Siadaty MS. et al. D-dimer testing for deep venous thrombosis: a metaanalysis. Clin Chem 2004; 50: 1136-47.
• 18 Lind SE, Pearce LA, Feiburg WM. et al. Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities. SPAF Investigators. Stroke Prevention in Atrial Fibrillation. Blood Coagul Fibrinolysis 1999; 10: 215-27.